Navigation Links
Low Abundance cDNA Cloned Using Stratagenes Human Universal ,,, cDNA Library



A time-saving alternative to conventional library plating and screening

Anuradha Mehta Donna Driscoll

Department of Cell Biology, Cleveland Clinic Foundation, Cleveland, OH

We chose Stratagenes Human Universal cDNA Library 1 (HUCL) to isolate a full-length cDNA clone encoding a novel low-abundance protein called Apobec-1 Complementation Factor (ACF) for several important reasons: The simple two-step hybridization protocol allowed us to quickly screen a large number of clones, normalization increased the chance of finding low-abundance cDNAs, the librarys varied tissue base aided in isolating a protein that was widely expressed but only in small amounts, and the average size of the library clones ranged within ACFs expected sequence size. We successfully isolated ACF cDNA, which was crucial in allowing us to define the minimal protein requirements for the C to U editing of apolipoprotein-B mRNA.

Purification of proteins and identification of their cognate cDNAs are powerful tools for studying the molecular mechanisms underlying biological systems. Highly sensitive mass spectrometric techniques provide valuable peptide sequence information from very limited amounts of protein, which can be used to screen the wealth of information available in the NCBI databasesincluding both nonredundant and Expressed Sequence Tag (EST) databases. In the case of a novel protein, identi
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
2. Oil-Free PCR Using the Hot Top Assembly
3. Functional Cloning Using ViraPort Retroviral cDNA Expression Libraries
4. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
5. Using XL1-Red Mutator Strain to Generate Esterase Variants
6. Detect Released Oligosaccharides Using the Eagle Eye II Still Video Imaging System
7. Comparison of Growth Techniques and Media for the Purpose of Plasmid Isolation from E. coli Using the Eppendorf Perfectprep Plasmid Mini Kit
8. Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood Mini Kit
9. Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood Mini Kit
10. Isolation of Genomic DNA from Saliva Using the Perfect gDNA Blood Mini Kit
11. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy

Post Your Comments:
(Date:11/8/2009)...9 Complete Genomics, a third-generation human gen...n of a report in the journal Science describing ... analysis of sequence data from three complete hum...enomes sequenced on the proof-of-principle genomic...e to $1,726 for 45x coverage for the samples descr...
(Date:11/6/2009)... Myriant Technologies LLC ("Myriant"), a privately...wable bio-chemicals, Uhde Corporation of America a...e of the world,s leading engineering contractors (...ineering, procurement & construction (EPC) of ...enewable feedstocks. The execution of this allian...
(Date:11/6/2009)...-- Intarcia Therapeutics, Inc. delivered two prese...uous delivery of exenatide) program for the treatm...s Technology Meeting in San Francisco, CA: ,, (...1/SFTU126LOGO ) ,, Continuous Subcutaneous De...cose, HbA1c and Reduces Weight in a 28-day Phase 1...
(Date:11/5/2009)... -- DSM Pharmaceutical Products today announced th...ix, Saint Jean D,Illac, France, where DSM will be ...er for Galenix commercial products on a global bas...ness development opportunities co-marketing Galeni...h of Galenix in drug product development and clini...
Breaking Biology Technology:Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...d, CAESAREA, Israel, March 26 Alma Lasers Ltd., ...nd radiofrequency systems,announces important deve...hich is being litigated in the United States Distr...e U.S. Patent and Trademark Office in,Alexandria V...menis,s,patents that are at issue in the litigatio...
...pril 1, 2008, LEVERKUSEN, Germany, and PITTSBURGH...ate MEDRAD, Inc. announced,today that it has succe...ding shares of common stock of Possis Medical, Inc...as advised MEDRAD that, as of the expiration,of th...ay, March 25, 2008,a total of 14,951,550 Possis Me...
...h CyberKnife System to Date, SUNNYVALE, Calif., M...global leader in the field of radiosurgery,announc...fe centers,worldwide are now treating lung cancer ...*. The number of lung cancer patients is growing,s...uals receiving,CyberKnife treatments to date., Lu...
Other Biology Technology:U.S. PTO Reexamining Lumenis Patents 2Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period 2Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period 3CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 2CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 3CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 4
(Date:11/4/2009)..., 2009 Childhood obesity in the United States is ...fourth of advertising on daytime and prime time te...uing questions about the role television plays in ... the Journal of Nutrition Education and Behavior ...ight be a large contributor to the problem. , Re...
(Date:11/4/2009)...., Oct. 19 Spectros, developer and...aging devices which shed light on life-threatening...usive distribution deals for both its T-Stat®...ered include Australia, New Zealand, The Netherla...y, France, Spain, Portugal, Poland, Greece, Turkey...
(Date:11/4/2009)... What,s the cost of saving a teenag...th resulting from prescription medication abuse, t... however, may be unaware that the lock-boxes they,...he ticking timebomb of prescription drugs. That,s ...ty medical supplies, has formed an exclusive partn...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Spectros Signs New International Distribution Deals 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3New biomarker method could increase the number of diagnostic tests for cancer 9054 1New biomarker method could increase the number of diagnostic tests for cancer 9054 2New biomarker method could increase the number of diagnostic tests for cancer 9054 3New biomarker method could increase the number of diagnostic tests for cancer 9054 4LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 1LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 2LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 3LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 4Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program 50315 1Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program 50315 2Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program 50315 3
...transplant patients reject their new organs requir...accept or reject each other. Xavier Fernndez-Busqu...y of Barcelona, has found the perfect ally in this...ies that grows abundantly from just north of Cape ...icrociona prolifera) has a cell-to-cell recognitio...
... water is a scene with which we,re all familiar. Y...rable amount of time in the water–polar bears, sea...a thick layer of body fat to keep warm. They rely,...ir fur and the densely packed layer of specially a...scopy and polarizing light microsopy, John W. Weis...
... water is a scene with which we,re all familiar. Y...rable amount of time in the water–polar bears, sea...a thick layer of body fat to keep warm. They rely,...ir fur and the densely packed layer of specially a...scopy and polarizing light microsopy, John W. Weis...
Other Biology News:Simple sea sponge helps scientists understand tissue rejection 2Genome Sequence for Haemophilus Influenzae Completed 2Genome Sequence for Haemophilus Influenzae Completed 3Otter adaptations: How do otters remain sleek and warm 2Otter adaptations: How do otters remain sleek and warm 3
Goat Anti-ZBP-89 (S-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Enolase from baker's yeast (S. cerevisiae) from Sigma-Aldrich
UNOsphere S Support, 100 ml from Bio-Rad
Baker's yeast (S. cerevisiae) Phosphoglucose isomerase from Sigma-Aldrich
Biology Products: